Novomedix LLC
Novomedix LLC is a biotechnology company based in San Diego, CA, specializing in the development of novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases. With decades of expertise in drug development, the company has established a robust pipeline utilizing their proprietary technology platform, featuring a library of oral small molecule IL-11 inhibitors.
The company's lead candidate, NMX1, targets mTOR signaling and IL-11 secretion, aiming to treat tumors while also activating AMPK to protect heart function in triple-negative breast cancer. Novomedix is committed to advancing multiple therapeutic candidates designed to address various fibrotic diseases, liquid tumors, and atopic dermatitis, reflecting its dedication to transforming patient care through innovative treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.